"Anthraquinones" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds based on ANTHRACENES which contain two KETONES in any position. Substitutions can be in any position except on the ketone groups.
| Descriptor ID |
D000880
|
| MeSH Number(s) |
D02.455.426.559.847.117.159 D02.806.100 D04.615.117.159
|
| Concept/Terms |
Anthraquinones- Anthraquinones
- Anthranoids
- Anthraquinone Derivatives
- Derivatives, Anthraquinone
- Anthracenediones
- Anthraquinone Compounds
- Compounds, Anthraquinone
|
Below are MeSH descriptors whose meaning is more general than "Anthraquinones".
Below are MeSH descriptors whose meaning is more specific than "Anthraquinones".
This graph shows the total number of publications written about "Anthraquinones" by people in this website by year, and whether "Anthraquinones" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 1 | 2 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anthraquinones" by people in Profiles.
-
Herbal Medicines for Constipation and Phytochemical Comparison of Active Components. Am J Chin Med. 2022; 50(3):723-732.
-
Biogeochemical dynamics and microbial community development under sulfate- and iron-reducing conditions based on electron shuttle amendment. PLoS One. 2021; 16(5):e0251883.
-
Chemical constituents of the plants from the genus Oplopanax. Chem Biodivers. 2014 Feb; 11(2):181-96.
-
Cystatin 10, a novel chondrocyte-specific protein, may promote the last steps of the chondrocyte differentiation pathway. J Biol Chem. 2003 Nov 28; 278(48):48259-66.
-
Phase I study of the combination of losoxantrone and cyclophosphamide in patients with refractory solid tumours. Br J Cancer. 2002 Feb 12; 86(4):534-9.
-
Elimination pathways of [14C]losoxantrone in four cancer patients. Drug Metab Dispos. 2001 Feb; 29(2):96-9.
-
Glucose-induced inhibition of in vitro bone mineralization. Bone. 2001 Jan; 28(1):21-8.
-
Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study. Cancer Treat Rep. 1984 Dec; 68(12):1511-2.
-
Mitoxantrone in malignant lymphomas. Cancer Treat Rev. 1983 Dec; 10 Suppl B:69-72.